Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Advocate Lutheran General Hospital, Park Ridge IL, United States



Survival: 10.0 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: United States
   
City/State/Province: Park Ridge IL
   
Hospital: Advocate Lutheran General Hospital
   
Journal: Link
   
Date: 4/2011

Description:
Patients:
This phase 2 study involved 26 previously treated non-Hodgkin lymphoma patients. The median patient age was 69 years and 45% were male.

Treatment:
Patients were treated with the chemotherapy agent clofarabine.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia, thrombocytopenia, and anemia.

Results:
The median overall survival was 10 months.

Support:
This study was supported by Genzyme, makers of clofarabine.

Correspondence: Dr. Chadi Nabhan; email: cnabhan@oncmed.net

E-mail to a Friend Email Physician More Information